Abstract
1. The ortho (M66,527) and para (M66,368) analogues of 1-t-butylamino-3-(methoxyphenoxy)-2-propanol and para substituted tertiary butylphenoxy-1-N-isopropylamine-3 propanol-2 oxalate acid (L8429) were tested in dogs for their β-adrenoceptor blocking activity.
2. M66,527, which contains a methoxy group in the ortho position of the benzene ring, was found to be comparable to propranolol in blocking cardiac and peripheral vascular responses to isoprenaline. Like propranolol, M66,527 was more potent on peripheral receptors.
3. Transference of the methoxy group to the para position (M66,368) reduced the overall potency; however, this compound was found to be relatively cardioselective in that it was 2 to 3·6 times more active in blocking cardiac responses to isoprenaline.
4. The cardioselective properties of the short chain para methoxy substituent were less than those reported for compounds with longer para substitutions (i.e. practolol, para oxprenolol and para alprenolol).
5. L8429, with a tertiary butyl group in the para position, was a weak β-adrenoceptor antagonist without cardioselective properties. A longer, less bulky n-butyl group may provide for a more potent and selective antagonist.
6. The results support the view that the size and site of the substituent on the benzene ring may be of importance in determining the cardioselective potency of β-adrenoceptor antagonists.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ablad B., Brogård M., Carlsson E., Ek L. Beta-adrenergic receptor blocking properties of three allyl-substituted phenoxypropanolamines. Eur J Pharmacol. 1970;13(1):59–64. doi: 10.1016/0014-2999(70)90183-4. [DOI] [PubMed] [Google Scholar]
- BAY E., COTTEN M. D. Direct measurement of changes in cardiac contractile force; relationship of such measurements to stroke work, isometric pressure gradient and other parameters of cardiac function. Am J Physiol. 1956 Sep;187(1):122–134. doi: 10.1152/ajplegacy.1956.187.1.122. [DOI] [PubMed] [Google Scholar]
- Crowther A. F., Howe R., Smith L. H. Beta-adrenergic blocking agents. 10. (3-amino-2-hydroxypropoxy)anilides. J Med Chem. 1971 Jun;14(6):511–513. doi: 10.1021/jm00288a012. [DOI] [PubMed] [Google Scholar]
- Dohadwalla A. N., Freedberg A. S., Vaughan Williams E. M. The relevance of beta-receptor blockade to ouabain-induced cardiac arrhythmias. Br J Pharmacol. 1969 Jun;36(2):257–267. doi: 10.1111/j.1476-5381.1969.tb09503.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gent G., Davis T. C., McDonald A. Practolol in treatment of supraventricular cardiac dysrhythmias. Br Med J. 1970 Feb 28;1(5695):533–535. doi: 10.1136/bmj.1.5695.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kayaalp S. O., Kiran B. K. Mechanism of a sympathomimetic action of propranolol in dog. Br J Pharmacol Chemother. 1966 Oct;28(1):15–22. doi: 10.1111/j.1476-5381.1966.tb01869.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nakano J., Kusakari T. Effect of propranolol on the peripheral circulation. Proc Soc Exp Biol Med. 1965 Nov;120(2):516–519. doi: 10.3181/00379727-120-30576. [DOI] [PubMed] [Google Scholar]
- Regoli D. Pressor action of beta blocking agents in rats. Can J Physiol Pharmacol. 1970 Jul;48(7):481–489. doi: 10.1139/y70-074. [DOI] [PubMed] [Google Scholar]
- Vaughan Williams E. M., Papp J. G. The effect of oxprenolol on cardiac intracellular potentials in relation to its anti-arrhythmic, local anaesthetic and other properties. Postgrad Med J. 1970 Nov;(Suppl):22–32. [PubMed] [Google Scholar]
- Williams E. M., Bagwell E. E., Singh B. N. Cardiospecificity of -receptor blockade. A comparison of the relative potencies on cardiac and peripheral vascular -adrenoceptors of propranolol, of practolol and its ortho-substituted isomer, and of oxprenolol and its para-substituted isomer. Cardiovasc Res. 1973 Mar;7(2):226–240. doi: 10.1093/cvr/7.2.226. [DOI] [PubMed] [Google Scholar]
- Yamamoto J., Sekiya A. Further studies on the pressor action of propranolol in the rat. Arch Int Pharmacodyn Ther. 1972 Aug;198(2):347–354. [PubMed] [Google Scholar]